Friederike Knipping

Friederike Knipping

Auto-generated profile, based on publicly available information

Friederike Knipping

Medical School, Department of Pediatrics, Division of Blood and Marrow Transplant & Cellular Therapy, University of Minnesota, Minneapolis, MN 55455, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
Mark OsbornMark Osborn
Mark Osborn
GNGregory Newby
Gregory Newby
AMAmber N. McElroy
Amber N. McElroy
FKFriederike Knipping
Friederike Knipping
SNSarah C. Nielsen
Sarah C. Nielsen
JTJakub Tolar
Jakub Tolar

1 January 2022 in Molecular Therapy
Verified
Journal Article
Open access
FKFriederike Knipping
Friederike Knipping
GNGregory Newby
Gregory Newby
CECindy R. Eide
Cindy R. Eide
AMAmber N. McElroy
Amber N. McElroy
SNSarah C. Nielsen
Sarah C. Nielsen
Mark OsbornMark Osborn
Mark Osborn
Disruption of CCR5 or CXCR4, the main human immunodeficiency virus type 1 (HIV-1) co-receptors, has been shown to protect primary human CD4+ T cells from HIV-1 infection. Base editing can install targeted point mutations in cellular genomes, and can thus efficiently inactivate genes by introducing stop codons or eliminating start codons without double-stranded DNA break formation. Here, we applied base editors for individual and simultaneous disruption of both co-receptors in primary human CD4+ T cells. Using cytosine base editors we observed premature stop codon introduction in up to 89% of sequenced CCR5 or CXCR4 alleles. Using adenine base editors we eliminated the start codon in CCR5 in up to 95% of primary human CD4+ T cell and up to 88% of CD34+ hematopoietic stem and progenitor cell target alleles. Genome-wide specificity analysis revealed low numbers of off-target mutations that were introduced by base editing, located predominantly in intergenic or intronic regions. We show that our editing strategies prevent transduction with CCR5-tropic and CXCR4-tropic viral vectors in up to 79% and 88% of human CD4+ T cells, respectively. The engineered T cells maintained functionality and overall our results demonstrate the effectiveness of base-editing strategies for efficient and specific ablation of HIV co-receptors in clinically relevant cell types.

12 February 2021 in Bioengineering
Verified
Journal Article
Open access
PDF file
Mark OsbornMark Osborn
Mark Osborn
ABAkshay Bhardwaj
Akshay Bhardwaj
SBSam Bingea
Sam Bingea
FKFriederike Knipping
Friederike Knipping
CFColby J Feser
Colby J Feser
JTJakub Tolar
Jakub Tolar
Clustered regularly interspaced short palindromic repeat (CRISPR/Cas) proteins can be designed to bind specified DNA and RNA sequences and hold great promise for the accurate detection of nucleic acids for diagnostics. We integrated commercially available reagents into a CRISPR/Cas9-based lateral flow assay that can detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences with single-base specificity. This approach requires minimal equipment and represents a simplified platform for field-based deployment. We also developed a rapid, multiplex fluorescence CRISPR/Cas9 nuclease cleavage assay capable of detecting and differentiating SARS-CoV-2, influenza A and B, and respiratory syncytial virus in a single reaction. Our findings provide proof-of-principle for CRISPR/Cas9 point-of-care diagnosis as well as a scalable fluorescent platform for identifying respiratory viral pathogens with overlapping symptomology.